These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 20853076)
21. Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model. Hanpanich P; Laha T; Sripa B; Mairiang E; Sereerak P; Upontain S; Tangkawattana P; Brindley PJ; Tangkawattana S Parasitol Int; 2017 Aug; 66(4):464-470. PubMed ID: 27143606 [TBL] [Abstract][Full Text] [Related]
22. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis. Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171 [TBL] [Abstract][Full Text] [Related]
23. A combination of liver fluke infection and traditional northeastern Thai foods associated with cholangiocarcinoma development. Sriraj P; Boonmars T; Aukkanimart R; Songsri J; Sripan P; Ratanasuwan P; Boonjaraspinyo S; Wongchalee N; Laummaunwai P Parasitol Res; 2016 Oct; 115(10):3843-52. PubMed ID: 27271702 [TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine. Juasook A; Boonmars T; Wu Z; Loilome W; Veteewuthacharn K; Namwat N; Sudsarn P; Wonkchalee O; Sriraj P; Aukkanimart R Pathol Oncol Res; 2013 Jan; 19(1):55-62. PubMed ID: 22851165 [TBL] [Abstract][Full Text] [Related]
25. Potentiation by the human liver fluke, Opisthorchis viverrini, of the carcinogenic action of N-nitrosodimethylamine upon the biliary epithelium of the hamster. Flavell DJ; Lucas SB Br J Cancer; 1982 Dec; 46(6):985-9. PubMed ID: 6295426 [No Abstract] [Full Text] [Related]
26. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model. Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086 [TBL] [Abstract][Full Text] [Related]
27. A combination of praziquantel and the traditional medicinal plant Thunbergia laurifolia on Opisthorchis viverrini infection and cholangiocarcinoma in a hamster model. Wonkchalee N; Boonmars T; Laummaunwai P; Aromdee C; Hahnvajanawong C; Wu Z; Sriraj P; Aukkanimart R; Chamgramol Y; Pairojkul C; Juasook A; Sudsarn P Parasitol Res; 2013 Dec; 112(12):4211-9. PubMed ID: 24057695 [TBL] [Abstract][Full Text] [Related]
28. Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model. Yothaisong S; Thanee M; Namwat N; Yongvanit P; Boonmars T; Puapairoj A; Loilome W Asian Pac J Cancer Prev; 2014; 15(23):10463-8. PubMed ID: 25556493 [TBL] [Abstract][Full Text] [Related]
29. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954 [No Abstract] [Full Text] [Related]
30. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection. Songserm N; Prasongwattana J; Sithithaworn P; Sripa B; Pipitkool V Asian Pac J Cancer Prev; 2009; 10(2):299-302. PubMed ID: 19537899 [TBL] [Abstract][Full Text] [Related]
31. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance. Yothaisong S; Namwat N; Yongvanit P; Khuntikeo N; Puapairoj A; Jutabha P; Anzai N; Tassaneeyakul W; Tangsucharit P; Loilome W Parasitol Int; 2017 Aug; 66(4):471-478. PubMed ID: 26657242 [TBL] [Abstract][Full Text] [Related]
32. [Role of opisthorchis felineus on induction of bile duct cancer]. Maksimova GA; Zhukova NA; Kashina EV; Lvova MN; Katokhin AV; Tolstikova TG; Mordvinov VA Parazitologiia; 2015; 49(1):3-11. PubMed ID: 26016330 [TBL] [Abstract][Full Text] [Related]
35. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. Yongvanit P; Pinlaor S; Loilome W J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859 [TBL] [Abstract][Full Text] [Related]
36. Expression of tenascin in bile duct cancer of hamster liver by combined treatment of dimethylnitrosamine with Opisthorchis viverrini infections. Sithithaworn P; Ando K; Limviroj W; Tesana S; Pairojkul C; Yutanawiboonchai W; Chinzei Y; Yoshida T; Sakakura T J Helminthol; 2002 Sep; 76(3):261-8. PubMed ID: 12363380 [TBL] [Abstract][Full Text] [Related]
37. Subtle to severe hepatobiliary morbidity in Opisthorchis viverrini endemic settings in southern Laos. Ayé Soukhathammavong P; Rajpho V; Phongluxa K; Vonghachack Y; Hattendorf J; Hongvanthong B; Rasaphon O; Sripa B; Akkhavong K; Hatz C; Odermatt P Acta Trop; 2015 Jan; 141(Pt B):303-9. PubMed ID: 25275346 [TBL] [Abstract][Full Text] [Related]
38. Inflammatory responses to Tangkawattana S; Suyapoh W; Thongrin T; Wendo WD; Salao K; Suttiprapa S; Saichua P; Tangkawattana P Open Vet J; 2024 Feb; 14(2):664-673. PubMed ID: 38549578 [TBL] [Abstract][Full Text] [Related]
39. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients. Chaiyarit P; Sithithaworn P; Thuwajit C; Yongvanit P Clin Oral Investig; 2011 Aug; 15(4):477-83. PubMed ID: 20446100 [TBL] [Abstract][Full Text] [Related]
40. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis. Rodpai R; Luvira V; Sadaow L; Sukeepaisarnjaroen W; Kitkhuandee A; Paonariang K; Sanpool O; Ittiprasert W; Mann VH; Intapan PM; Brindley PJ; Maleewong W Int J Infect Dis; 2022 Mar; 116():80-84. PubMed ID: 34954313 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]